Combined Review to Facilitate Speedier Set Up for Clinical Research Trials

On 15 July 2021 the UK MHRA announced it will publish a combined review of all new clinical trials of IMPs in the UK beginning January 2022.

From January 2022, all new Clinical Trials of Investigational Medicinal Products (CTIMPs) in the UK will be subject to a combined review from the MHRA and the UK Research Ethics Services, in collaboration with the Health Research Authority (HRA), facilitating rapid start up and benefitting patients sooner.

Applicants need only make a single application for both Clinical Trial Authorisation and Research Ethics Committee (REC) opinion and approval is delivered together.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /